The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
Open accessAbstract
In the present study, we investigated the role of the CD40L-CD40 pathway in a model of progressive atherosclerosis. ApoE−/− mice were treated with an anti-CD40L antibody or a control antibody for 12 wk. Antibody treatment started early (age 5 wk) or was delayed until after the establishment of atherosclerosis (age 17 wk). In both the early and delayed treatment groups, anti-CD40L antibody did not decrease plaque area or inhibit lesion initiation or age-related increase in lesion area. The morphology of initial lesions was not affected, except for a decrease in T-lymphocyte content. Effects of anti-CD40L antibody treatment on the morphology of advanced lesions were pronounced. In both the early and delayed treatment groups, T-lymphocyte content was significantly decreased. Furthermore, a pronounced increase in collagen content, vascular smooth muscle cell/myofibroblast content, and fibrous cap thickness was observed. In the delayed treatment group, a decrease in lipid core and macrophage content occurred. Interestingly, advanced lesions of anti-CD40L antibody-treated mice exhibited an increased transforming growth factor β1 immunoreactivity, especially in macrophages. In conclusion, both early and delayed treatment with an anti-CD40L antibody do not affect atherosclerotic lesion initiation but do result in the development of a lipid-poor collagen-rich stable plaque phenotype. Furthermore, delayed treatment with anti-CD40L antibody can transform the lesion profile from a lipid-rich to a lipid-poor collagen-rich phenotype. Postulated mechanisms of this effect on plaque phenotype are the down-regulation of proinflammatory pathways and up-regulation of collagen-promoting factors like transforming growth factor β.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., et al. (1996) · Nature · doi:10.1038/381434a0 · Cited by 1,455
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.9.1512 · Cited by 965
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910
Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90668-g · Cited by 814
Mach, F., Schönbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1931 · Cited by 732
IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39
Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E., & Noelle, R. J. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.591 · Cited by 626
Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C., & Spriggs, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.669 · Cited by 578
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
Mach, F., Schönbeck, U., Bonnefoy, J.-Y., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A., Ledbetter, J. A., Boersma, W. J., & Claassen, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2499 · Cited by 488
Transforming growth factor beta: the good, the bad, and the ugly.
Wahl, S. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1587 · Cited by 486
Prevention of Collagen-Induced Arthritis with an Antibody to gp39, the Ligand for CD40
Durie, F. H., Fava, R. A., Foy, T. M., Aruffo, A., Ledbetter, J. A., & Noelle, R. J. (1993) · Science · doi:10.1126/science.7689748 · Cited by 457
Requirement for CD154 in the progression of atherosclerosis
Lutgens, E., Gorelik, L., Daemen, M. J. A. P., de Muinck, E. D., Grewal, I. S., Koteliansky, V. E., & Flavell, R. A. (1999) · Nature Medicine · doi:10.1038/15271 · Cited by 439
Self-citationRathmell, J. C., Townsend, S. E., Xu, J. C., Flavell, R. A., & Goodnow, C. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81349-5 · Cited by 408
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 356
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M., & Metcalfe, J. C. (1994) · Nature · doi:10.1038/370460a0 · Cited by 352
Schönbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J.-Y., Fabunmi, R. P., & Libby, P. (1997) · Circulation Research · doi:10.1161/01.res.81.3.448 · Cited by 334
Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.
Yellin, M. J., Brett, J., Baum, D., Matsushima, A., Szabolcs, M., Stern, D., & Chess, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1857 · Cited by 273
Leonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogl, S., Dargel, R., & Poli, G. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.11.9285483 · Cited by 264
Smith, J. D., Bryant, S. R., Couper, L. L., Vary, C. P. H., Gotwals, P. J., Koteliansky, V. E., & Lindner, V. (1999) · Circulation Research · doi:10.1161/01.res.84.10.1212 · Cited by 197
Self-citationCD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells
Schönbeck, U., Mach, F., Sukhova, G. K., Herman, M., Graber, P., Kehry, M. R., & Libby, P. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64699-8 · Cited by 160
Bobik, A., Agrotis, A., Kanellakis, P., Dilley, R. J., Krushinsky, A. V., Smirnov, V. N., Tararak, E. M., Condron, M. M., & Kostolias, G. (1999) · Circulation · doi:10.1161/01.cir.99.22.2883 · Cited by 157
Stearns, M. E., Rhim, J. S., & Wang, M. (1999) · PubMed · Cited by 126
CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines
Kornbluth, R. S., Kee, K., & Richman, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5205 · Cited by 124
Atherosclerosis in APOE*3-Leiden Transgenic Mice: From Proliferative to Atheromatous Stage
Lutgens, E., Daemen, M. J. A. P., Kockx, M. M., Doevendans, P. A., Hofker, M. H., Havekes, L. M., Wellens, H. J. J., & de Muinck, E. D. (1999) · Circulation · doi:10.1161/01.cir.99.2.276 · Cited by 115
Self-citationReul, R. M., Fang, J. C.-T., Denton, M., Geehan, C. S., Long, C. G., Mitchell, R. N., Ganz, P., & Briscoe, D. M. (1997) · Transplantation · doi:10.1097/00007890-199712270-00025 · Cited by 113
Reckless, J., Metcalfe, J. C., & Grainger, D. J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1542 · Cited by 92
Adawi, A., Zhang, Y., Baggs, R. B., Rubin, P., Williams, J. P., Finkelstein, J. N., & Phipps, R. P. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4606 · Cited by 83
CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line
Hess, S., Gottfried, E., Smola, H., Grunwald, U., Schuchmann, M., & Engelmann, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3594::aid-immu3594>3.0.co;2-d · Cited by 40
Regulation of the Thrombotic Potential of Atheroma
Mach, F., Schönbeck, U., Bourcier, T., Aikawa, M., & Libby, P. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615905 · Cited by 30
Cited by
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
INFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,019
Metadata
- Authors
- Lutgens, E., Cleutjens, K. B. J. M., Heeneman, S., Koteliansky, V. E., Burkly, L. C., & Daemen, M. J. A. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-06-20
- Volume
- 97
- Issue
- 13
- Pages
- 7464-7469
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2094026225
- Cited by
- 271
- References
- 36
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.